Epidemiology, outcomes of treatment, and survival of cervical cancer in Kazakhstan: a nationwide population-based study - Scorecard - MDSpire

Epidemiology, outcomes of treatment, and survival of cervical cancer in Kazakhstan: a nationwide population-based study

  • By

  • Aidana Rakhmankulova

  • Yesbolat Sakko

  • Abduzhappar Gaipov

  • Kuralay Atageldiyeva

  • Talshyn Ukybassova

  • Assem Suleimenova

  • Yerbolat Iztleuov

  • Gulzhanat Aimagambetova

  • June 5, 2026

  • 0 min

Share

Clinical Scorecard: Cervical Cancer in Kazakhstan: A Nationwide Study on Epidemiology, Treatment Outcomes, and Survival Rates

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationWomen in Kazakhstan, particularly those aged 11-13 for vaccination (source needed).
Care Setting

Key Highlights

  • 5-year survival rate

Guideline-Based Recommendations

Diagnosis

    Management

    • R
    • e
    • m
    • o
    • v
    • e
    • i
    • n
    • t
    • e
    • r
    • p
    • r
    • e
    • t
    • a
    • t
    • i
    • v
    • e
    • l
    • a
    • n
    • g
    • u
    • a
    • g
    • e
    • u
    • n
    • l
    • e
    • s
    • s
    • d
    • i
    • r
    • e
    • c
    • t
    • l
    • y
    • s
    • u
    • p
    • p
    • o
    • r
    • t
    • e
    • d
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Remove unsupported claims about years of life lost.

        Clinical Best Practices

        • best_practices

        Related Resources & Content

        Original Source(s)

        Epidemiology, outcomes of treatment, and survival of cervical cancer in Kazakhstan: a nationwide population-based study

        • by Aidana Rakhmankulova, Yesbolat Sakko, Abduzhappar Gaipov, Kuralay Atageldiyeva, Talshyn Ukybassova, Assem Suleimenova, Yerbolat Iztleuov, Gulzhanat Aimagambetova

        • June 5, 2026

        Related Content

        What RevMed’s pancreatic cancer drug meant for one patient

        Case Report: Zoledronic acid-induced hyperprogression in oncology: a case study of RET-driven neuroendocrine carcinoma treated with Selpercatinib

        Quality of life, morbidity, mortality, and long-term prognosis after craniopharyngioma